LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00066667
 41.84 84.90 3078 4003 0.7689 0.9077
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 43.55 84.90 526 4287 0.1227 0.3803
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 43.55 84.90 3369 4287 0.7857 0.9165
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 43.55 84.90 543 4287 0.1266 0.3881
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 43.55 84.90 3304 4287 0.7705 0.9100
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 45.25 84.90 620 4539 0.1366 0.4139
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 45.25 84.90 3619 4539 0.7972 0.9226
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 45.25 84.90 604 4539 0.1330 0.4075
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 45.25 84.90 3501 4539 0.7712 0.9115
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 46.95 84.90 645 4952 0.1302 0.4129
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 46.95 84.90 3805 4952 0.7683 0.9121
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 46.95 84.90 641 4952 0.1294 0.4114
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 46.95 84.90 3739 4952 0.7550 0.9064
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 48.65 84.90 715 5328 0.1342 0.4288
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 48.65 84.90 4051 5328 0.7602 0.9103
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 48.65 84.90 717 5328 0.1346 0.4294
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 48.65 84.90 4015 5328 0.7535 0.9074
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 50.36 84.90 837 5651 0.1481 0.4591
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 50.36 84.90 4267 5651 0.7551 0.9094
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 50.36 84.90 772 5651 0.1366 0.4398
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 50.36 84.90 4210 5651 0.7450 0.9051
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 52.06 84.90 897 5990 0.1497 0.4680
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 52.06 84.90 4441 5990 0.7413 0.9049
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 52.06 84.90 865 5990 0.1444 0.4594
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 52.06 84.90 4472 5990 0.7465 0.9070
MN20160318_Q02
D18